-+ 0.00%
-+ 0.00%
-+ 0.00%

CVS Health Affirms FY2026 GAAP EPS Guidance of $5.94-$6.14 vs $5.74 Est

Benzinga·02/10/2026 11:32:20
Listen to the news

2026 Full-Year Guidance

  • Confirmed GAAP diluted EPS guidance range of $5.94 to $6.14
  • Confirmed Adjusted EPS guidance range of $7.00 to $7.20
  • Updated cash flow from operations guidance to at least $9.0 billion from at least $10.0 billion